关于我们

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.

所属行业
制药业
规模
5,001-10,000 人
总部
Boulogne Billancourt
类型
上市公司
领域
Pharmaceuticals、Specialty care: oncology, neuroscience, endocrinology、Research: peptides, toxins和Primary Care

地点

Ipsen员工

动态

相似主页

融资

Ipsen 共 1 轮

上一轮

上市后股权

US$29,134,597.00

Crunchbase 上查看更多信息